Loading

$53 million investment will let PanTheryx take DiaResQ global

The Denver Post – PanTheryx has hauled in a $53 million investment that will fund the global launch of DiaResQ, a medical nutrition product used to treat acute infectious diarrhea, a leading killer of children worldwide. Learn more.